230 related articles for article (PubMed ID: 24388862)
1. Tobacco control policies specified according to socioeconomic status: health disparities and cost-effectiveness.
Over EA; Feenstra TL; Hoogenveen RT; Droomers M; Uiters E; van Gelder BM
Nicotine Tob Res; 2014 Jun; 16(6):725-32. PubMed ID: 24388862
[TBL] [Abstract][Full Text] [Related]
2. Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.
Kaper J; Wagena EJ; van Schayck CP; Severens JL
Pharmacoeconomics; 2006; 24(5):453-64. PubMed ID: 16706571
[TBL] [Abstract][Full Text] [Related]
3. Possible methodological reason for the finding that "Neither tax increase nor reimbursement reduced health disparities": comment on the article by by Over et al. (2014).
van der Deen FS; Wilson N; Blakely T
Nicotine Tob Res; 2014 Jul; 16(7):1030. PubMed ID: 24638851
[No Abstract] [Full Text] [Related]
4. Reply to the comment by Van der Deen et al.: "Possible methodological reason for the finding that 'Neither tax increase nor reimbursement reduced health disparities'".
Over EA; Feenstra TL; Hoogenveen RT; Droomers M; Uiters E; van Gelder BM
Nicotine Tob Res; 2014 Jul; 16(7):1031-2. PubMed ID: 24759894
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
[TBL] [Abstract][Full Text] [Related]
6. Increasing tobacco taxes: a cheap tool to increase public health.
van Baal PH; Brouwer WB; Hoogenveen RT; Feenstra TL
Health Policy; 2007 Jul; 82(2):142-52. PubMed ID: 17050031
[TBL] [Abstract][Full Text] [Related]
7. Health, Health Inequality, and Cost Impacts of Annual Increases in Tobacco Tax: Multistate Life Table Modeling in New Zealand.
Blakely T; Cobiac LJ; Cleghorn CL; Pearson AL; van der Deen FS; Kvizhinadze G; Nghiem N; McLeod M; Wilson N
PLoS Med; 2015 Jul; 12(7):e1001856. PubMed ID: 26218517
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD.
Németh B; Józwiak-Hagymásy J; Kovács G; Kovács A; Demjén T; Huber MB; Cheung KL; Coyle K; Lester-George A; Pokhrel S; Vokó Z
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):76-86. PubMed ID: 29368363
[TBL] [Abstract][Full Text] [Related]
10. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis.
Verguet S; Gauvreau CL; Mishra S; MacLennan M; Murphy SM; Brouwer ED; Nugent RA; Zhao K; Jha P; Jamison DT
Lancet Glob Health; 2015 Apr; 3(4):e206-16. PubMed ID: 25772692
[TBL] [Abstract][Full Text] [Related]
11. Simulated effect of tobacco tax variation on population health in California.
Kaplan RM; Ake CF; Emery SL; Navarro AM
Am J Public Health; 2001 Feb; 91(2):239-44. PubMed ID: 11211632
[TBL] [Abstract][Full Text] [Related]
12. Free nicotine replacement therapy programs vs implementing smoke-free workplaces: a cost-effectiveness comparison.
Ong MK; Glantz SA
Am J Public Health; 2005 Jun; 95(6):969-75. PubMed ID: 15914818
[TBL] [Abstract][Full Text] [Related]
13. Behavioral change in response to a statewide tobacco tax increase and differences across socioeconomic status.
Parks MJ; Kingsbury JH; Boyle RG; Choi K
Addict Behav; 2017 Oct; 73():209-215. PubMed ID: 28551589
[TBL] [Abstract][Full Text] [Related]
14. Are financial incentives cost-effective to support smoking cessation during pregnancy?
Boyd KA; Briggs AH; Bauld L; Sinclair L; Tappin D
Addiction; 2016 Feb; 111(2):360-70. PubMed ID: 26370095
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of tax and price policies in tobacco control.
Chaloupka FJ; Straif K; Leon ME;
Tob Control; 2011 May; 20(3):235-8. PubMed ID: 21115556
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of smoker support for increasing a dedicated tobacco tax: national survey data from New Zealand.
Wilson N; Weerasekera D; Edwards R; Thomson G; Devlin M; Gifford H
Nicotine Tob Res; 2010 Feb; 12(2):168-73. PubMed ID: 20018943
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.
Higashi H; Barendregt JJ
Addiction; 2012 Mar; 107(3):658-70. PubMed ID: 21883602
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
[TBL] [Abstract][Full Text] [Related]
19. A Cost-Effectiveness Analysis of Stop Smoking Interventions in Substance-Use Disorder Populations.
Healey A; Roberts S; Sevdalis N; Goulding L; Wilson S; Shaw K; Jolley C; Robson D
Nicotine Tob Res; 2019 Apr; 21(5):623-630. PubMed ID: 29733376
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD.
Anraad C; Cheung KL; Hiligsmann M; Coyle K; Coyle D; Owen L; West R; de Vries H; Evers SM; Pokhrel S
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):96-105. PubMed ID: 29430762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
